Versican: A Dynamic Regulator of the Extracellular Matrix

Area of Science:

• Biochemistry
• Cell Biology
• Extracellular Matrix Biology

Background:

• Versican is a large chondroitin sulfate/dermatan sulfate proteoglycan.
• It is a structural component of the extracellular matrix in adult brain and blood vessels.
• Versican expression is upregulated during development, inflammation, repair, and in cancer, correlating with aggressiveness.

Purpose of the Study:

• To review the role of versican in inflammation and cancer.
• To discuss the biological functions of versican fragments, particularly the N-terminal G1 domain fragment (versikine).

Main Methods:

• Literature review of studies on versican.
• Analysis of versican splice variants (V0, V1, V2, G3) and their glycosaminoglycan attachment domains (CSα, CSβ).
• Discussion of versican degradation by ADAMTS proteinases.

Main Results:

• Versican's involvement in dynamic extracellular matrix changes during pathological conditions.
• Upregulation of versican is linked to cancer aggressiveness.
• The N-terminal G1 domain fragment exhibits various biological functions, though mechanisms are not fully understood.

Conclusions:

• Versican is a significant modulator of extracellular matrix during inflammation and cancer.
• Further research is needed to elucidate the precise mechanisms of action for versican fragments like versikine.